These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30972627)

  • 1. Upregulation of the Intestinal Paracellular Pathway with Breakdown of Tight and Adherens Junctions in Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Mol Neurobiol; 2019 Oct; 56(10):7056-7073. PubMed ID: 30972627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakdown of the Paracellular Tight and Adherens Junctions in the Gut and Blood Brain Barrier and Damage to the Vascular Barrier in Patients with Deficit Schizophrenia.
    Maes M; Sirivichayakul S; Kanchanatawan B; Vodjani A
    Neurotox Res; 2019 Aug; 36(2):306-322. PubMed ID: 31077000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia phenomenology comprises a bifactorial general severity and a single-group factor, which are differently associated with neurotoxic immune and immune-regulatory pathways.
    Maes M; Vojdani A; Geffard M; Moreira EG; Barbosa DS; Michelin AP; Semeão LO; Sirivichayakul S; Kanchanatawan B
    Biomol Concepts; 2019 Nov; 10(1):209-225. PubMed ID: 31734647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Schizophrenia, Increased Plasma IgM/IgA Responses to Gut Commensal Bacteria Are Associated with Negative Symptoms, Neurocognitive Impairments, and the Deficit Phenotype.
    Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
    Neurotox Res; 2019 Apr; 35(3):684-698. PubMed ID: 30552634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.
    Maes M; Andrés-Rodríguez L; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    CNS Neurol Disord Drug Targets; 2023; 22(2):215-225. PubMed ID: 35946099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficit Schizophrenia Is Characterized by Defects in IgM-Mediated Responses to Tryptophan Catabolites (TRYCATs): a Paradigm Shift Towards Defects in Natural Self-Regulatory Immune Responses Coupled with Mucosa-Derived TRYCAT Pathway Activation.
    Kanchanatawan B; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Mar; 55(3):2214-2226. PubMed ID: 28290151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach.
    Maes M; Sirivichayakul S; Matsumoto AK; Michelin AP; de Oliveira Semeão L; de Lima Pedrão JV; Moreira EG; Barbosa DS; Carvalho AF; Solmi M; Kanchanatawan B
    Mol Neurobiol; 2020 Nov; 57(11):4578-4597. PubMed ID: 32754898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory and Oxidative Pathways Are New Drug Targets in Multiple Episode Schizophrenia and Leaky Gut, Klebsiella pneumoniae, and C1q Immune Complexes Are Additional Drug Targets in First Episode Schizophrenia.
    Maes M; Vojdani A; Sirivichayakul S; Barbosa DS; Kanchanatawan B
    Mol Neurobiol; 2021 Jul; 58(7):3319-3334. PubMed ID: 33675500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    CNS Neurol Disord Drug Targets; 2017; 16(4):472-483. PubMed ID: 28403801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supervised machine learning to decipher the complex associations between neuro-immune biomarkers and quality of life in schizophrenia.
    Kanchanatawan B; Sriswasdi S; Maes M
    Metab Brain Dis; 2019 Feb; 34(1):267-282. PubMed ID: 30467771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions.
    Sirivichayakul S; Kanchanatawan B; Thika S; Carvalho AF; Maes M
    CNS Neurol Disord Drug Targets; 2019; 18(2):124-140. PubMed ID: 30451122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.
    Kanchanatawan B; Thika S; Sirivichayakul S; Carvalho AF; Geffard M; Maes M
    Neurotox Res; 2018 Apr; 33(3):641-655. PubMed ID: 29380275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In schizophrenia, psychomotor retardation is associated with executive and memory impairments, negative and psychotic symptoms, neurotoxic immune products and lower natural IgM to malondialdehyde.
    Maes M; Sirivichayakul S; Kanchanatawan B; Carvalho AF
    World J Biol Psychiatry; 2020 Jun; 21(5):383-401. PubMed ID: 32031479
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis.
    Ciccia F; Guggino G; Rizzo A; Alessandro R; Luchetti MM; Milling S; Saieva L; Cypers H; Stampone T; Di Benedetto P; Gabrielli A; Fasano A; Elewaut D; Triolo G
    Ann Rheum Dis; 2017 Jun; 76(6):1123-1132. PubMed ID: 28069576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.
    Kanchanatawan B; Hemrungrojn S; Thika S; Sirivichayakul S; Ruxrungtham K; Carvalho AF; Geffard M; Anderson G; Maes M
    Mol Neurobiol; 2018 Jun; 55(6):5184-5201. PubMed ID: 28875464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.
    Roomruangwong C; Kanchanatawan B; Sirivichayakul S; Anderson G; Carvalho AF; Duleu S; Geffard M; Maes M
    Metab Brain Dis; 2017 Oct; 32(5):1571-1583. PubMed ID: 28600633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Construct a Bottom-Up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia.
    Maes M; Vojdani A; Galecki P; Kanchanatawan B
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32957709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    Kanchanatawan B; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome.
    Maes M; Kanchanatawan B; Sirivichayakul S; Carvalho AF
    Mol Neurobiol; 2019 Jul; 56(7):5122-5135. PubMed ID: 30484113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs.
    Kanchanatawan B; Sirivichayakul S; Carvalho AF; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):205-216. PubMed ID: 28690204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.